–
Bicara Therapeutics Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY22:
FY23:
−45.6
FY24:
−74.8
FY25:
−107
Change from FY22 to FY25
millions USD
FY22:
−0.19
FY23:
−0.59
FY24:
−0.01
FY25:
−318
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
272
FY24:
334
FY25:
32.3
millions USD
FY22:
–
FY23:
226
FY24:
259
FY25:
−393
(positive)
Change from FY22 to FY25
millions USD
FY22:
−32.3
FY23:
−46.2
FY24:
−74.8
FY25:
−107
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.